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Abstract: The genus Yersinia contains three well-recognized human pathogens, including Y.
enterocolitica, Y. pestis, and Y. pseudotuberculosis. Various domesticated and wild animals carry
Yersinia in their intestines. Spread to individuals arises from eating food or water contaminated
by infected human or animal faeces. Interaction with infected pets and domestic stock may also
lead to infection. Yersinia is able to multiply at temperatures found in normal refrigerators; hence,
a large number of the bacteria may be present if meat is kept without freezing. Yersinia is also rarely
transmitted by blood transfusion, because it is able to multiply in stored blood products. Infection
with Yersinia can cause yersiniosis, a serious bacterial infection associated with fever, abdominal
pain and cramps, diarrhea, joint pain, and symptoms similar to appendicitis in older children and
adults. This paper describes a novel immunosensor approach using graphene quantum dots (GQDs)
as enzyme mimics in an electrochemical sensor set up to provide an efficient diagnostic method
for Y. enterecolitica. The optimum assay conditions were initially determined and the developed
immunosensor was subsequently used for the detection of the bacterium in milk and human serum.
The GQD-immunosensor enabled the quantification of Y. enterocolitica in a wide concentration
range with a high sensitivity (LODmilk = 5 cfu mL−1 and LODserum = 30 cfu mL−1) and specificity.
The developed method can be used for any pathogenic bacteria detection for clinical and food samples
without pre-sample treatment. Offering a very rapid, specific and sensitive detection with a label-free
system, the GQD-based immunosensor can be coupled with many electrochemical biosensors.
Keywords: Yersinia enterocolitica; pathogen detection; graphene quantum dots (GQDs);
GQD-immunosensor; enzyme mimics; infectious diseases
1. Introduction
Yersinia enterocolitica is a gram-negative bacillus shaped bacterium that leads to a zootonic disease
called yersiniosis. The infection is demonstrated as mesenteric adenitis, acute diarrhea, terminal ileitis,
and pseudoappendicitis. Rarely, it can even result in sepsis [1]. According to the 2017 report of the
European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control
(ECDC), Y. enterocolitica has been realized as the third most common foodborne-zoonotic disease after
campylobacteriosis and salmonellosis in the European Union [2].
Nutrients are stored in refrigerators for a long time at 4 ◦C and Y. enterocolitica has the ability
to quickly and easily grow and proliferate at this temperature. This situation increases the risk of
infection via contaminated food and dairy products [1]. The bacterium is transmitted to humans
by contaminated water and food. Raw and pasteurized milk, as well as various vegetables, may be
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particular sources of this pathogen [1]. In 1982, Y. enterocolitica was found in pasteurized milk and led
to an outbreak in Arkansas [3]. Several studies suggested that the bacterium cannot survive after a
proper pasteurization process [4,5], although contrary findings were also reported [6]. The quick and
accurate detection of the bacterium from food products or the body fluids of infected individuals is,
therefore, important [1].
Several techniques have been used for the detection of Y. enterocolitica, including cultivation
methods [7], serological tests [8], enzyme link immunosorbent assay (ELISA) [9], and polymerase
chain reaction (PCR)-based tests [10,11]. Despite being well-established techniques, they are subject
to some major limitations associated with assay complexity, the necessity for a long analysis time,
and the possibility of obtaining false positive results due to the cross-reactions with other infectious
diseases. Biosensors offer strong alternatives to these techniques for rapid and sensitive quantification
of Y. enterocolitica. Various transducer systems, such as surface plasmon resonance (SPR) [12,13], fiber
optic [14], and electrochemical [15,16] sensors, have been used for this aim. Although the applications
of sensor technologies in pathogenic bacteria determination are very common, the number of Yersinia
sensors reported in the literature are limited to a few examples. More importantly, these sensors
were not coupled with the nanomaterials that provide significantly higher sensitivity, specificity,
and reproducibility than those of traditional sensors.
Among the nanomaterials, graphene quantum dots (GQDs) are particularly attractive for label-free
detection techniques for microorganisms [17,18]. They are defined as zero-dimensional (0D) materials
with characteristics derived from both graphene and carbon dots, which can be considered exceedingly
small pieces of graphene. By turning 2D graphene sheets into 0D GQDs, the GQDs display new
phenomena owing to quantum confinement and edge effects, which are akin to carbon dots [19].
Compared with semiconductive quantum dots and organic dyes, GQDs are superior in terms of
their exceptional properties, such as biocompatibility, low toxicity, and high photostability against
photobleaching and blinking [18,19]. Unlike carbon dots, GQDs clearly possess a graphene structure
inside the dots, irrespective of the dot size, which confers them with some of the unusual properties of
graphene [19]. GQDs have, therefore, attracted significant attention from researchers in different fields
since 2000 [17–21].
GQDs possess peroxidase (POD)-like catalytic activities, where the reactions involve the oxidation
of an electron-donor substrate with the concurrent reduction of hydrogen peroxide (H2O2). [19,22,23]
Horseradish peroxidase (HRP) is the most commonly used peroxidase in biosensing applications,
which require the labelling of a secondary receptor for target determination, thus making the assay
procedures time-consuming and costly. Acting as nanozymes, HRP-based systems can be replaced
by GQDs that allow the label-free detection of analytes. Guo et al. assembled the GQDs on a gold
electrode, where the GQDs showed highly peroxidase-like properties even after being assembled
on gold. The as-prepared GQDs-Au electrode showed good electrochemical catalytic properties toward
the H2O2 decomposition. Electrochemical measurements showed that the GQDs-Au electrode bears a
fast amperometric response to H2O2, a wide linear range, and a low detection limit [22]. Yang et al.
recently reported a label-free electrochemical immunosensor, where the GQDs efficiently reduced
H2O2 and allowed the sensitive detection of carcinoembryonic antigen (CEA) in human serum [23].
GQDs have the ability to increase the electrochemical reaction speed and this is particularly
important to consider while developing electrochemical sensors [19]. To avoid sample pre-treatment
and bestow a rapid and easy-to-apply detection principle, we have developed an immunoassay with
GQDs due to their aforementioned characteristics. We introduced an electrochemical sensing approach
for highly sensitive and specific determination of Y. enterocolitica in milk and human serum for the
first time. To this end, the activated GQDs were laminated on a gold electrode prior to the antibody
immobilization, followed by inactivating unreacted carboxyl groups on the surface with bovine serum
albumin (BSA) and ethanolamine (EA) (Scheme 1). The quantification of bacterium was achieved
based on the reduction of H2O2 by GQDs. The bare gold electrode surface could not reduce H2O2
itself, whereas the GQD-modified gold electrode significantly reduced H2O2 and generated gradually
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increasing signals at mA range based on the increasing GQD concentration used. The enhanced
electrocatalytic property of the GQD-modified electrode could be attributed to the intimate electronic
interactions between Au and GQDs, which improves electron transfer. The detection of bacteria was
based on the degree of inhibited electron transfer of the laminated GQDs on the Au surface, which
was hampered by the formation of antigen–antibody complex on the GQD-modified Au electrode.
Thus, the signal response of the immunosensor decreased along with the increased Y. enterecolitica
concentration in the sample solution. To best of our knowledge, we could achieve the highest sensitivity
and specificity for Y. enterocolitica by using the label-free, real time GQDs-based electrochemical sensor.
This may help in the identification of possible infectious diseases and any pathogenic bacteria which
exist in food products.
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2. Materials and Methods
2.1. Materials and Reagents
A monoclonal anti-Y. enterocolitica antibody was bought from BIO-RAD (Puchheim, Germany).
Heat-killed Y. enterocolitica, Salmonella typhimurium, Bacillus anthracis, Y. pestis and Eschericia coli
were purchased from SeraCare Life Sciences (Gaithersburg, MD, USA). Sterile human serum,
1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC), N- hidroxysuccinimide (NHS), ethanolamine,
analytical grade ethanol, hydrogen peroxide, phosphate-buffered saline tablets (PBS, 0.01 M), graphene
quantum dots (<5 nm) were bought from Sigma Aldrich (Poole, UK). Milk was obtained from a local
market. Bovine serum albumin (BSA) was purchased from Merck (Darmstadt, Germany). Double
distilled water was produced by a Milli-Q water system (Millipore Corp., Tokyo, Japan).
2.2. Fabrication, Cleaning and Coating of Working Electrodes
The electrodes were laid out on the glass slide using a fine metal mask, which was made of a
laser-cut patterned stainless steel. Gold was deposited on the wafer using an electron beam evaporator
(Ebeam system Nanovak NVEB-600, Nanovak, Ankara, Turkey). Prior to the application of Au
(200 nm), a 40 nm Ti layer was implemented onto the wafer as an intermediary adhesive layer to
enhance the adhesion between the glass slide and the Au [24]. The electrodes were then washed
with double distilled water and dried thoroughly under a stream of nitrogen gas. Electrochemical
measurements were performed using a Keithley-4200 semi-conductor parameter analyzer KTE I
version (V9.1). The illustration of electrodes and the measurement set up are presented in Figure 1.
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Figure 1. (A) Illustration of electrodes. (B) A picture of electrodes. (C) Electrochemical measurement
set up of Keithley-4200 semi-conductor parameter analyzer KTE I version (V9.1).
The electrodes were cleaned by employing nitrogen plasma prior to laminating the EDC-NHS
activated GQDs on the sensing surfaces [25]. The GQDs, diluted in double distilled water, were
mixed with E C (0.4 M)-NHS (0.1 M) solution in a tube, which was stirred on a shaker for 8 h at 4 ◦C.
A 200 µL of this solution was then injected o to the gold working electrodes a d incubated overnight
to laminate the GQDs on the surface.
2.3. Determination of Optimal GQDs Concentration for Bioassays
The morphology and uniformity of GQDs were initially characterized using a transmission
electron microscope (TEM, JEM-2100, JEOL Ltd. Tokyo, Japan). The GQD sample was prepared by
filtering 10 µL through a 1.2 µm glass fiber syringe filter and depositing the filtrate on a silicon chip
attached to a TEM holder, and leaving them to dry overnight in a fume hood prior to measurement.
Six different concentrations of GQDs (0.5, 5, 50, 500, 5000 and 50,000 ppm) were prepared in double
distilled water and then measured on the bare electrode surface to determine the optimum GQD
concentration based on the signal/concentration relationship towards the reduction of 5 mM H2O2.
The experiments for each concentration were repeated three times and the optimum GQD concentration
was determined for bioassays according to average electrochemical sensor signals.
2.4. Antibody Immobilization and Characterization
The GQD-laminated sensor surface was washed with PBS buffer (pH: 7.4) prior to the covalent
immobilization of the anti-Y. enterocolitica antibody (50 µg mL−1, prepared in NaAc buffer, pH 4.5)
during 1 h incubation. To inactivate the remaining carboxyl groups on the surface and avoid possible
non-specific interactions during the analyte detection assays, the electrodes were incubated with BSA
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(100 µg mL−1, prepared in PBS buffer) and ethanolamine (1 M, prepared in double distilled water,
pH 8.5) for 4 min each. Each step of antibody immobilization was performed at room temperature in a
Petri dish to protect it from dust or evaporation. All reagents (antibody, BSA, ethanolamine) were
applied to the sensor surface at 200 µL volume. Between the subsequent steps the sensor surface was
carefully rinsed with PBS buffer (pH 7.4). The bare gold, GQD-laminated, and antibody-immobilized
sensor surfaces were characterized by an atomic force microscope (AFM) (Naio, Nanosurf AG, Liestal,
Switzerland). Commercially available AFM probes (NCLR) from NanoWorld (NanoWorld AG, Liestal,
Switzerland) were used for the measurements at a spring constant of 23.191 N/m, resonant frequency
of 170,481 Hz, scan size of 3.027 µm, and scan speed of 2 s. All AFM measurements were carried out at
room temperature using the intermittent air mode.
2.5. Development of the Bioassay for Milk Samples
The initial assays were carried out in PBS buffer in a concentration range of 1–6.23 × 108 cfu mL−1
using 5000 ppm of GQDs. For the assays in milk (50%, diluted with buffer), two sets of samples were
prepared to determine the most convenient GQD concentration that is necessary for the quantification
of Y. enterocolitica at lowest possible level. One set of milk samples contained 6 cfu mL−1 of the
bacterium, whereas the second set comprised of 6.23 × 108 cfu mL−1. Each sample set was measured
on two different electrode surfaces, which were prepared with GQDs at a concentration of 5000
or 50,000 ppm. The bacteria samples (200 µL) were incubated on the anti-Y. enterocolitica antibody
immobilized electrode surfaces for 8 min, washed with PBS prior to the amperometric measurements
at −0.2 V in the presence of H2O2 (5 mM in PBS) [23]. Accordingly, the detection of bacterium in a
wide concentration range was investigated using the electrodes prepared with 5000 ppm GQDs.
2.6. Development of the Bioassay for Human Serum Samples
The optimum concentration of GQDs for serum assays was investigated as described in Section 2.5.
As the lower amount of GQD (5000 ppm) did not allow the quantification of the bacterium at 6 cfu mL−1,
the higher GQD concentration (50,000 ppm) was selected. The quantification of Y. enterocolitica from 1
to 6.23 × 108 cfu mL−1 was then studied using the GQD immunosensor. Each sample was injected
onto the antibody immobilized surface at a volume of 200 µL, incubated for 8 min, and measured
electrochemically in the presence of H2O2 (5 mM in PBS). All bioassays were performed using 50% of
human serum diluted with buffer.
3. Results and Discussions
3.1. Determination of Optimal GQDs Concentration for Bioassays
In this study, GQDs (<5 nm) were used as nanozymes replacing enzymatic systems. The intimate
electronic interactions between the Au electrode and GQDs supplied high electrical conductivity
and catalytic surface area, which turned them into the exceedingly active electrocatalysts for H2O2
reduction [22,23]. In this study, we first determined the convenient amount of GQDs for use in sensor
development, based on the signal–concentration relationship. The GQDs resulted in sensor signals at
mA range on the bare gold electrodes surfaces. Among the six different concentrations tested, 5000 ppm
was initially selected for use in bioassays. This concentration led to 23.8 ± 2.5 mA response, which is
significantly higher than normal bioassay systems, where the measured concentration of an analyte
generally results in a response ranging from µA to nA. Although the higher GQDs concentration
(50,000 ppm) led to a 38.76 ± 2.6 mA response, it was not chosen because this would have increased
the cost of the developed system (Figure 2).
The uniform size and morphology of the GQDs were confirmed by employing TEM (Figure 3).
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3.2. Label Free Direct Assay for Y. enterocolitica Determination in Milk and Human Blood
The initial investigations for Y. enterocolitica detection were carried out in buffer to establish
the bioassays. The bacterium specific antibody was covalently immobilized to the GQD-laminated
Au electrode surface. The bare, GQD-laminated, and antibody-immobilized sensor surfaces were
characterized by AFM (Figure 4). The 3D surface topology images in 1 × 1 µm2 scanning area resulted
in the heights of 12 nm, 18.5 nm, and 23.4 nm for bare (Figure 4A), GQD-laminated (Figure 4B),
and antibody-immobilized (Figure 4C) surfaces, respectively. The gradual increase of the surface
height confirmed the successful preparation of the sensing surface for bacteria detection assays [26].
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Figure 4. AFM analysis of bare (A), GQD-laminated (B), and antibody-immobilized (C) sensor surfaces.
Eight Y. enterocolitica samples (1–6.23 × 108 cfu mL−1) were prepared in PBS buffer (pH 7.4).
These samples were then injected onto the sensor surface and the measurements were carried out
using a three electrode system connected to a Keithley-4200 semi-conductor parameter analyzer.
A 5000 ppm concentration of GQDs was sufficient to quantify 1 cfu mL−1 of Y. enterocolitica in
200 µL (the actual LOD was 5 cfu mL−1). However, the lower GQDs concentration (i.e., 500 ppm)
could not provide this sensitivity level. The individual real time measurement results of bacteria
detection are given in Figure 5A. The overall results of the assays in PBS buffer were subjected
to logarithmic regression analysis, revealing R2 values of 0.98 and 0.92 in the concentration range
of 6.23 × 102 -6.23 × 108 cfu mL−1 and 1–6.23×108 cfu mL−1, respectively (Figure 5B). The lowest
concentration of the bacterium generated a 2.8 ± 0.1 mA signal in buffer, which is significantly higher
than those of earlier studies (~20 nA for 50 cfu mL−1 of E. coli), where HRP was used as the enzyme
label in AuNP amplified sandwich assay in buffer [27]. This confirms the excellent properties of GQDs
as enzyme mimics for biosensing applications. Moreover, the current bioassay strategy does not require
the conjugation of nanomaterials with a secondary antibody, which decreases the cost and provides
easy-to-apply sensor arrays [24,27].
To ensure the optimum GQD amount for milk and serum assays, we first tested two different
concentrations of Y. enterecolitica (6 and 6.23 × 108 cfu mL−1) by using the working electrodes prepared
with 5000 or 50,000 ppm GQD. The lower GQD concentration (5000 ppm) was selected for milk
assays, as it allowed the quantification of 6 cfu mL−1 of the bacterium with a sufficient sensor signal
(17.2 ± 2.1 nA). On the other hand, this GQD concentration did not generate a signal in human serum
for 6 cfu mL−1 of Y. enterecolitica and led to only 120 ± 20 pA signal for the highest concentration of the
bacterium (6.23 × 108 cfu mL−1). This is attributed to the presence of various interfering compounds in
human serum, such as hormones, minerals, and proteins. Based on the preliminary tests, the assays in
milk and serum were performed using the GQD concentrations of 5000 and 50,000 ppm, respectively
(Figure 6).
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assays, as it allowed the quantification of 6 cfu mL-1 of the bacterium with a sufficient sensor signal 
(17.2 ± 2.1 nA). On the other hand, this GQD concentration did not generate a signal in human serum 
for 6 cfu mL-1 of Y. enterecolitica and led to only 120 ± 20 pA signal for the highest concentration of the 
bacterium (6.23 × 108 cfu mL−1). This is attributed to the presence of various interfering compounds 
in human serum, such as hormones, minerals, and proteins. Based on the preliminary tests, the assays 
in milk and serum were performed using the GQD concentrations of 5000 and 50,000 ppm, 
respectively (Figure 6).  
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Ten different concentrations of the bacterium, from 1 to 6.23 × 108 cfu·mL−1, were spiked in
milk and serum. Each sample was injected to the antibody i mobilized sensor for amperometric
measurements at −0.2V. The lowest amounts of Y. enterocolitica measured in milk and se um we 1 an
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were prepared as 1 mL solutions and only 200 µL of the samples were injected to the el c ode surfac
for measurements. Therefore, the actual LODs of milk and s rum assays were determi ed to be 5 and
30 cfu mL−1, respectively. The overall results of bioassay for milk and seru sampl are given in
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Figure 6. Optimization of GQD concentration for milk (A, B) and serum (C, D) assays by testing two
different concentrations (6 and 6.23 × 108 cfu mL−1) of Y. enterecolitica (n = 3).
The current methods for Y. enterecolitica detection include cultivation [7], ELISA [9], PCR [10,11],
and SPR-based tests [12,13]. These techniques are either labor intensive or time consuming, and lack the
desired sensitivity. The limit of detection of these methods varies between 102-106 cfu mL−1 (Table 1).
A few electrochemical sensors have been reported for the detection of Yersinia species, targeting bacteria
specific genes [15,16,28]. The direct detection of bacteria using electrochemical transducers has not
been studied so far. Additionally, although the nanomaterials integrated sensors have dominated in
pathogenic bacteria detection in recent years [22,25,29,30], to best of our knowledge, such a system has
not been introduced for Yersinia determination. Compared to our earlier works [24,27], reporting on
the quantification of E. coli in water (LOD: 50 cfu·mL−1) and Salmonella typhimirium in human stool
(LOD: 12 cfu mL−1) using gold nanoparticles amplified electrochemical sensors, we achieved higher
sensitivities (LODmilk= 5 cfu mL−1, LODserum= 30 cfu mL−1) in the current work, despite working with
more complex media. It is worth noting that we performed a static assay procedure in the current
work with a limited sample volume. In case of applying the developed strategy for fully automated
microfluidic systems, we expect the sensitivity of the assays to increase, which may lead to quantifying
one single bacterium. The current work allows label-free detection of Y. enterocolitica with a direct
assay methodology, not requiring enzyme labels and detector antibody. The superior features of
GQD-immunosensor supply a much shorter assay time than those of previous studies [24,27].
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Table 1. Comparison of various techniques for the detection of Y. enterecolitica.
Method Sample Ligand Investigation Range Detection Limit Ref
ELISA Dairy product Antibody 5-1000 cfu g−1 10 cfu g−1 [9]
Chemiluminescent ELISA Human fecal/ bovine meat Antibody 102-108 cfu mL−1 104-105 cfu mL−1 [31]
ELISA Pig diaphragm musclesamples Antibody 2-4.75 log10 cfu g
−1 3.56 log10 cfu g−1 [32]
Multiplex PCR Pig feces Ail gene P/N P/N [33]
Real-time PCR and ELISA Wild boar tonsils/feaces Ail gene P/N P/N [34]
SPR sensor Buffer Protein G 102-107 cfu mL−1 102 cfu mL−1 [12]
Imaging ellipsometry
immunosensor Buffer Antibody 10
3-107 cfu mL−1 103 cfu mL−1 [13]
DNA microarray chip
hybridization Various food matrices DNA 10
3-106 cfu g−1 104 cfu g-1 * [35]
GQD sensor Milk Antibody 1-6.23 × 108 cfu mL−1 5 cfu mL−1 CW
GQD sensor Human serum Antibody 1-6.23 × 108 cfu mL−1 30 cfu mL−1 CW
P/N—positive/negative; *, the ail gene of bacterium was quantified; CW—current work.
3.3. Cross-Reactivity Studies for Y. enterocolitica
To determine t e specificity of the developed assay forY. enterocolitica, the interaction of non-specific
bacteria with the bacterium-specific antibody-immobilized sensor was studied. For this, the reference
samples of S. enteritidis, B. anthracis, E. coli, and Y. peptis were separately prepared in milk and human
serum at a fix concentration of 107 cfu mL−1. Each sample was injected to the antibody immobilized
surfaces and me sured during 200 s. An extr mely low cross-r a vity was r corded for all reference
pathogens in milk, suggesting a very high specificity of the bioassay for the target bacterium (Table 2).
The relative cross-reactivities of the non-specific pathogenic bacteria were found to be higher in human
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serum (Table 3) compared to milk. However, the maximum cross-reaction was still at an acceptable
level (22.8%), which was recorded for another Yersinia species. It is also worth noting that the selected
concentration of bacteria in cross-reactivity tests was quite high.
Table 2. Current response profile for Y. enterocolitica binding in milk compared with other pathogenic
bacteria, and the percentage of cross reactivity of non-specific bacteria (n = 3).
Bacteria Tested (107 cfu mL−1) Response (Current, nA) GQD Immunosensor % Relative Activity
Yersinia enterocolitica 1473.0 100.0 ± 2.0
Yersinia pestis 93.2 6.0 ± 2.0
Salmonella enteritidis 27.4 1.9 ± 0.2
Escherichia coli 9.2 0.6 ± 0.1
Bacillus anthracis 1.0 0.0 ± 0.0
Mix (− Y. pestis) * 1441.0 97.8 ± 1.5
Mix (+ Y. pestis) ** 1392.0 94.5 ± 2.2
* Measurement of Y. enterecolitica in a mixture of three non-specific bacteria excluding Y. pestis. ** Measurement of
Y. enterecolitica in a mixture of four non-specific bacteria including Y. pestis.
Table 3. Current response profile for Y. enterocolitica binding in human serum compared with other
pathogenic bacteria, and the percentage of cross reactivity of non-specific bacteria (n = 3).
Bacteria Tested (107 cfu mL−1) Response (Current, nA) GQD Immunosensor % Relative Activity
Yersinia enterocolitica 12.0 100.0 ± 2.0
Yersinia pestis 2.7 22.8 ± 2.0
Salmonella enteritidis 1.1 9.3 ± 0.3
Escherichia coli 1.0 8.3 ± 0.2
Bacillus anthracis 0.5 4.5 ± 0.1
Mix (− Y. pestis) * 10.5 87.5 ± 1.5
Mix (+ Y. pestis) ** 9.1 75.8 ± 2.3
* Measurement of Y. enterecolitica in a mixture of three non-specific bacteria excluding Y. pestis. ** Measurement of Y.
enterecolitica in a mixture of four non-specific bacteria including Y. pestis.
To realize the applicability of the GQD-immunosensor in the co-existence of various bacteria
species, we mixed the target bacterium and non-specific bacteria at equal concentrations (107 cfu·mL−1),
and subsequently measured the sensor signal to determine the relative activity for Y. enterecolitica.
Considering that Y. pestis led to higher cross-reactivity for individual tests as being another Yersinia
genus, we prepared two different mixtures of non-specific bacteria: 1) A mixture of S. enteritidis, E. coli,
and B. anthracis; and 2) a mixture of S. enteritidis, E. coli, B. anthracis, and Y. pestis. The relative activity
of the sensor for milk assays decreased only 2.2% and 5.5% in mixtures 1 and 2, respectively (Table 2).
The suppression of the sensor signal in serum was determined to be higher, with 12.5% and 24.2%
decrease in relative activity in mixtures 1 and 2, respectively (Table 3). Nevertheless, these results
suggest that GQD-immunosensor is capable of quantifying the target bacterium at high specificity
even in the co-existence of several non-specific bacteria.
4. Conclusions
In this work, a novel GQD-based immunosensor was developed using an electrochemical
transducer. Among all methods reported for the detection of Y. enterecolitica, the GQDs-enriched sensor
supplied the highest selectivity and sensitivity in complex media, such as milk (LOD: 5 cfu·mL−1) and
human serum (LOD: 30 cfu·mL−1). The developed method can be used for any pathogenic bacteria
detection for clinical and food samples without pre-sample treatment. Offering a very rapid, specific
and sensitive detection with a label-free system, the GQD-based immunosensor can be coupled with
various electrochemical biosensors.
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